The stock will begin trading on a split-adjusted basis on December 16 under the same ticker. ・Intelligent Bio Solutions will have roughly 959,533 outstanding shares after the split takes effect. ・The ...

Intelligent Bio Solutions Inc. INBS recently announced positive initial results from its Pharmacokinetic (PK) study. The study is important for supporting FDA 510(k) clearance of the company’s ...

An update from Intelligent Bio Solutions ( ($INBS) ) is now available. On October 16, 2025, Intelligent Bio Solutions Inc. held its annual ...

Monday, Intelligent Bio Solutions Inc. (NASDAQ:INBS) stock is trading higher with a session volume of 62.49 million compared to the average volume of 154k, as per data from Benzinga Pro. The company ...

Intelligent Bio Solutions has announced the exercise of previously issued warrants for $1.77 million in gross proceeds. Shares were down approximately 40% at last check. Today's manic market swings ...

Intelligent Bio Solutions Inc. INBS recently announced that it has secured a key patent in the United States relating to the Intelligent Fingerprinting Drug Screening Cartridge. This is the company’s ...

The reverse stock split was approved by Intelligent Bio Solutions’ stockholders at the annual meeting of the Company’s stockholders held on October 16, 2025, with the final ratio to be determined by ...